| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 371.44B | 376.78B | 372.17B | 299.10B | 278.27B |
| Gross Profit | 87.78B | 153.09B | 141.67B | 111.90B | 108.35B |
| EBITDA | 73.02B | 128.43B | 137.66B | -15.25B | 126.75B |
| Net Income | 66.97B | 89.00B | 96.22B | -22.76B | 89.94B |
Balance Sheet | |||||
| Total Assets | 1.22T | 1.15T | 1.07T | 948.47B | 958.78B |
| Cash, Cash Equivalents and Short-Term Investments | 373.31B | 334.20B | 167.64B | 128.59B | 146.72B |
| Total Debt | 138.95B | 130.76B | 133.57B | 127.68B | 119.25B |
| Total Liabilities | 502.47B | 502.23B | 499.21B | 466.78B | 443.85B |
| Stockholders Equity | 717.42B | 649.37B | 561.27B | 473.42B | 506.20B |
Cash Flow | |||||
| Free Cash Flow | 25.04B | 11.62B | 29.79B | 21.76B | 26.14B |
| Operating Cash Flow | 45.97B | 30.59B | 49.20B | 37.22B | 39.42B |
| Investing Cash Flow | -44.49B | -10.29B | -32.66B | -87.60B | 29.39B |
| Financing Cash Flow | 2.23B | -10.36B | -14.40B | -1.66B | -28.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $1.03T | 16.21 | 9.78% | ― | 0.60% | -36.83% | |
70 Outperform | $267.80B | 11.41 | 13.81% | 1.55% | 2.31% | 44.49% | |
69 Neutral | $282.07B | 16.54 | 15.45% | 2.14% | 7.22% | 48.18% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $835.73B | 15.75 | 15.95% | 1.79% | 1.89% | 12.32% | |
66 Neutral | $377.06B | 13.28 | 10.15% | 1.93% | 0.15% | 33.84% | |
61 Neutral | $263.51B | 13.89 | 11.78% | 1.80% | -4.37% | 26.41% |